Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand
A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia
Lung Foundation Australia and The Thoracic Society of Australia and New Zealand (TSANZ) have endorsed the position statement which highlights the current evidence for the treatment of IPF, with particular application to the Australian and New Zealand population. The paper also considers areas in which evidence is currently lacking, especially with regard to the broader IPF severity spectrum and treatment of co-morbid conditions. The utility of non-pharmacological therapies including pulmonary rehabilitation, oxygen as well as symptom management thought to be important in the holistic care of IPF patients are also discussed.